. 2020 Feb 17;30(6):3371–3382. doi: 10.1007/s00330-020-06678-z

Table 2.

Diagnostic performance estimates and cutoff values for tCho to distinguish benign (n = 29) from malignant (n = 74) breast lesions

Parameter	AUC	p value	tCho cutoff in mmol/l	Sensitivity (95% CI) in %	Specificity (95% CI) in %
tCho (R1)	0.816	< 0.0001	0.8	96.0 (88.6–99.2)	48.3 (29.4–67.5)
tCho (R2)	0.809	< 0.0001	0.8	97.3 (90.6–99.7)	44.8 (26.4–64.3)

Parameter

AUC

p value

tCho cutoff in mmol/l

Sensitivity
(95% CI) in %

Specificity
(95% CI) in %

tCho (R1)

0.816

< 0.0001

0.8

96.0

(88.6–99.2)

48.3

(29.4–67.5)

tCho (R2)

0.809

< 0.0001

0.8

97.3

(90.6–99.7)

44.8

(26.4–64.3)